The Defense Health Agency is a joint, integrated Combat Support Agency that enables the Army, Navy, and Air Force medical services to provide a medically ready force and ready medical force to Combatant Commands in both peacetime and wartime. The DHA uses the principles of Ready Reliable Care to advance high reliability practices across the Military Health System by improving our system operations, driving innovative solutions, and cultivating a culture of safety.
What We Do
The DHA’s global workforce of almost 140,000 civilians and military personnel is committed to medical excellence, health care improvement and ensuring military personnel are ready to perform combat operations and humanitarian missions at home and abroad.
DHA At-a-Glance
- On Oct. 1, 2018, began a four-year transition to assume authority, direction and control of the DOD’s more than 400 clinics, hospitals, and medical centers.
- Currently Operates 10 enterprise support activities at the DHA Headquarters level to ensure standardization across the Military Health System.
- Manages procurement and distribution of an $11 billion a year medical supply chain including about 560,000 medical devices, for the Joint Force.
- Enables a global network of military and civilian health care professionals to provide care to 9.6 million service members, retirees and family members.
Department of Defense Directive 3000.06, Effective July 8, 2016, Combat Support Agencies
Our Priorities
- Enabling Combat Support to the Joint Force in Competition, Crisis, or Conflict
- Building a Modernized, Integrated, and Resilient Health Delivery System
- Dedicated and Inspired Teams of Professionals Driving Military Health's Next Evolution
DHA supports the Military Departments and the Combatant Commands through the provision of enterprise support activities, providing medical capabilities across the Joint Force. Those activities include:
You also may be interested in...
Congressional Testimony
11/21/2019
H.R. 5516, NDAA for FY 2019, Section 711(c) (Defense Health Command)
Congressional Testimony
10/4/2019
H.R. 1625 DOD Approps Act FY 2018 Joint Explanatory Statement, Pg. 998
Congressional Testimony
5/15/2019
HR 1625, DOD Approps Act FY 2018, (1st quarter report for FY 2019), Joint Explanatory Statement, Pg. 998
Page 1 of 1
, showing items 1 - 3
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil
View the external links disclaimer.
Last Updated: April 07, 2023